HIF1A and ovarian carcinoma: Recently, we have confirmed the formation of IL-6/STAT3/HIF-1α autocrine signaling loop in ovarian cancer cells in vitro and in vivo, which confers chemoresistance against cisplatin to ovarian cancer [27].